Page 9 - Read Online
P. 9

Topic:  Reviews  of  Recent  Advances  in  Research  and  Treatment  for
                         Gastroenterological Malignancies


            Epithelial-mesenchymal transition in gastroenterological cancer

                                                                                  1
                                                                                                 1
                                                                    1
                                                  1
                         1
                                       1
            Hirohisa Okabe , Kosuke Mima , Seiya Saito , Hiromitsu Hayashi , Katsunori Imai , Hidetoshi Nitta ,
                                             1
                             1
            Daisuke Hashimoto , Akira Chikamoto , Takatoshi Ishiko , Toru Beppu , Hideo Baba 1
                                                                        2
                                                             1
            1 Department of Gastroenterological Surgery, Graduate School of Life Sciences, Kumamoto University, Kumamoto 860-8556, Japan.
            2 Department of Multidisciplinary Treatment for Gastroenterological Cancer, Kumamoto University Hospital, Kumamoto 860-8556, Japan.
            Correspondence to: Prof. Hideo Baba, Department of Gastroenterological Surgery, Graduate School of Life Science, Kumamoto University, 1-1-1 Honjo,
            Kumamoto City, Kumamoto 860-8556, Japan. Email: hdobaba@kumamoto-u.ac.jp
                                                     ABSTRACT
            Epithelial-mesenchymal  transition  (EMT)  was  fi rst  reported  as  an  essential  process  in  embryonic  cells  and  later  showed  that
            cancer  cells,  regardless  of  the  context,  exhibited  a  similar  phenomenon  that  was  crucial  for  tumor  progression.  Epithelial  cells
            lose their adhesive characteristic capacity which is necessary for their functions but gain a mesenchymal phenotype. This change
            from epithelial to the mesenchymal phenotype of cancer cells makes it diffi cult to understand the mechanism underlying cancer
            biology  and  tumor  progression. A  number  of  transcription  factors  involved  in  tumor  cell  EMT  and  microRNA-regulated  EMT
            have been reported. This review discussed recent fi ndings and new players in EMT in gastrointestinal cancers. Since the molecular
            mechanisms  of  tumor  progression  are  sometimes  context-dependent,  the  recent  fi ndings  of  EMT  have  been  reviewed  in  a
            context-dependent manner.
            Key words: Epithelial-mesenchymal transition, gastrointestinal cancer, microRNA, transcription factor

            Introduction                                      Esophageal Cancer

            Epithielial-mesenchymal transition (EMT) is a well-known   Esophageal  cancer  (    EC)  has  two  distinct  histological
            phenotype  and  essential  for  tumor  invasion  and   subtypes,  that  is,  esophageal  squamous  cell  carcinoma
            metastasis. [1-3]  The phenotype change in EMT is drastic, so   (ESCC)  and  esophageal  adenocarcinoma  (EAC).   The
                                                                                                        [4]
            the theory has fascinated many investigators, and several   former commonly occurs in Asia, whereas the latter is
            mechanisms  have  been  reported  to  date.  However,  the   common  in  the  United  States  and  Western  countries.
            number  of  factors  essential  for  EMT  is  increasing;  thus,   Transforming growth factor-β1 (TGF-β1) was reported
            it  is  challenging  to  integrate  those  factors  to  understand   to  induce  EMT  in  EAC  via  the  mothers  against
            their  networking.  In  this  review,  we  briefl y  updated  the       decapentaplegic  homolog  (SMAD)  4  pathway  and
            recent  EMT  fi ndings  in  a  context-dependent  manner,   this  signaling  was  inhibited  by  bone  morphogenetic
            because the mechanisms underlying a disease substantially   protein 7, another member of the TGF-β1 superfamily.
                                                                                                            [5]
            depend  on  the  original  function  of  the  affected  organ.   Using  immortalized  esophageal  keratinocyte,  TGF-β1
            Theoretically, the concept of EMT explains various cancer   was  shown  to  regulate  mitochondrial  superoxide
            characteristics  including  tumor  cell  invasion,  metastasis,   dismutase  2  (SOD2)  which  possesses  antioxidant
            chemo  resistance  and  stem  cell  phenotype;  therefore,  it   activity, to convert CD44  to CD44   cells. Expression
            has  considerable  clinical  signifi cance.  Thus,  this  review   of SOD2 was transcriptionally regulated by NF-κB and
                                                                                   low
                                                                                             high
            explores  both  the  molecular  mechanism  of  EMT  and  its   zinc  fi nger  E-box  binding  homeobox  2  (ZEB2),  but
            clinical signifi cance.
                                                              not  ZEB1.   In  the  same  cells,  it  was  also  reported
                                                                        [6]
            Although many EMT players, such as transcription factors   that  TGF-β1-mediated  EMT  required  p53  mutation
            and  microRNAs  (miRNAs)  have  been  introduced  so  far   accompanied  by  up-regulation  of  ZEB1  and  the  loss
            such as transcription factors and miRNAs, their roles are   of  epithelial  growth  factor  receptor  (EGFR)-dependent
            to  some  extent-dependent  on  the  context.  Therefore,  we
            discussed the role of each molecule in a context-dependent   This is an open access article distributed under the terms of the Creative
            manner to clarify the specifi c role of each player.  Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows
                                                              others to remix, tweak, and build upon the work non-commercially, as long as
                                                              the author is credited and the new creations are licensed under the identical
                           Access this article online         terms.
              Quick Response Code:                            For reprints contact: reprints@medknow.com
                                 Website:
                                 www.jcmtjournal.com
                                                               How to cite this article: Okabe H, Mima K, Saito S, Hayashi H,
                                                               Imai K, Nitta H, Hashimoto D, Chikamoto A, Ishiko T, Beppu T, Baba H.
                                                               Epithelial-mesenchymal transition in gastroenterological cancer. J
                                 DOI:                          Cancer Metastasis Treat 2015;1:183-9.
                                 10.4103/2394-4722.165118
                                                               Received: 27-07-2015; Accepted: 12-08-2015.

                © 2015 Journal of Cancer Metastasis and Treatment ¦ Published by Wolters Kluwer - Medknow  183
   4   5   6   7   8   9   10   11   12   13   14